These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29112657)

  • 41. Pregnancy loss managed by cervical dilatation and curettage increases the risk of spontaneous preterm birth.
    McCarthy FP; Khashan AS; North RA; Rahma MB; Walker JJ; Baker PN; Dekker G; Poston L; McCowan LM; O'Donoghue K; Kenny LC;
    Hum Reprod; 2013 Dec; 28(12):3197-206. PubMed ID: 24052504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder.
    Gibson AP; Bettinger TL; Patel NC; Crismon ML
    Ann Pharmacother; 2006 Jun; 40(6):1134-42. PubMed ID: 16735655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical significance of primary symptoms in women with placental abruption.
    Mei Y; Lin Y
    J Matern Fetal Neonatal Med; 2018 Sep; 31(18):2446-2449. PubMed ID: 28629246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of the Placenta in Preterm Birth: A Review.
    Morgan TK
    Am J Perinatol; 2016 Feb; 33(3):258-66. PubMed ID: 26731184
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage.
    Roberge S; Bujold E; Nicolaides KH
    Am J Obstet Gynecol; 2018 May; 218(5):483-489. PubMed ID: 29305829
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identifying risk factors for placental abruption in subsequent pregnancy without a history of placental abruption.
    Goldbart A; Pariente G; Sheiner E; Wainstock T
    Int J Gynaecol Obstet; 2023 May; 161(2):406-411. PubMed ID: 36083780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence and determinants of attention deficit/hyperactivity disorder (ADHD) medication use during pregnancy: Results from the Quebec Pregnancy/Children Cohort.
    Lemelin M; Boukhris T; Zhao JP; Sheehy O; Bérard A
    Pharmacol Res Perspect; 2021 May; 9(3):e00781. PubMed ID: 34003597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combining 2nd-trimester maternal serum homocysteine levels and uterine artery Doppler for prediction of preeclampsia and isolated intrauterine growth restriction.
    Onalan R; Onalan G; Gunenc Z; Karabulut E
    Gynecol Obstet Invest; 2006; 61(3):142-8. PubMed ID: 16374017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety of Treatments for ADHD in Adults: Pairwise and Network Meta-Analyses.
    Chierrito de Oliveira D; Guerrero de Sousa P; Borges Dos Reis C; Tonin FS; Maria Steimbach L; Virtuoso S; Fernandez-Llimos F; Pontarolo R; Cristina Conegero Sanches A
    J Atten Disord; 2019 Jan; 23(2):111-120. PubMed ID: 28366111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of Shorter Height with Increased Risk of Ischaemic Placental Disease.
    Ogawa K; Morisaki N; Saito S; Sato S; Fujiwara T; Sago H
    Paediatr Perinat Epidemiol; 2017 May; 31(3):198-205. PubMed ID: 28317131
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of maternal attention deficit hyperactivity disorder and preterm birth: a cohort study.
    Hesselman S; Wikman A; Skoglund C; Kopp Kallner H; Skalkidou A; Sundström-Poromaa I; Wikström AK
    BJOG; 2020 Nov; 127(12):1480-1487. PubMed ID: 32384173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The predictive value of sonographic placental markers for adverse pregnancy outcome in women with chronic kidney disease.
    Moloney A; Hladunewich M; Manly E; Hui D; Ronzoni S; Kingdom J; Stratulat V; Zaltz A; Barrett J; Melamed N
    Pregnancy Hypertens; 2020 Apr; 20():27-35. PubMed ID: 32145525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study.
    Huybrechts KF; Bateman BT; Pawar A; Bessette LG; Mogun H; Levin R; Li H; Motsko S; Scantamburlo Fernandes MF; Upadhyaya HP; Hernandez-Diaz S
    BMJ; 2020 Feb; 368():m237. PubMed ID: 32075794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiovascular Safety of Atomoxetine and Methylphenidate in Patients With Attention-Deficit/Hyperactivity Disorder in Japan: A Self-Controlled Case Series Study.
    Zheng Y; Fukasawa T; Yamaguchi F; Takeuchi M; Kawakami K
    J Atten Disord; 2024 Feb; 28(4):439-450. PubMed ID: 38084080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany.
    Greven P; Sikirica V; Chen YJ; Curtice TG; Makin C
    Eur J Health Econ; 2017 Sep; 18(7):893-904. PubMed ID: 27817164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder.
    Ince Tasdelen B; Karakaya E; Oztop DB
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):494-500. PubMed ID: 26218871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.
    Newcorn JH; Kratochvil CJ; Allen AJ; Casat CD; Ruff DD; Moore RJ; Michelson D;
    Am J Psychiatry; 2008 Jun; 165(6):721-30. PubMed ID: 18281409
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Successful Management of Methylphenidate or Atomoxetine-Related Priapism During Attention-Deficit Hyperactivity Disorder Treatment.
    Karayagmurlu A; Coskun M
    J Clin Psychopharmacol; 2020; 40(3):314-315. PubMed ID: 32332473
    [No Abstract]   [Full Text] [Related]  

  • 59. ADHD Medication Trends in Turkey: 2009-2013.
    Öner Ö; Yilmaz EŞ; Karadağ H; Vural M; Vural EH; Akbulat A; Gürsöz H; Türkçapar H; Kerman S
    J Atten Disord; 2017 Dec; 21(14):1192-1197. PubMed ID: 24554298
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort.
    Männistö T; Mendola P; Grewal J; Xie Y; Chen Z; Laughon SK
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2725-33. PubMed ID: 23744409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.